kt 6149 has been researched along with Adenocarcinoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ardiet, C; Catimel, G; De Bruijn, E; Dirix, L; Dumortier, A; Evene, E; Joossens, E; Koier, I; Provè, A; Schrijvers, D | 1 |
Ashizawa, T; Gomi, K; Hirata, T; Okabe, M | 1 |
Asami, N; Inaba, M; Morimoto, M; Sudo, Y; Tsuruo, T | 1 |
Abe, O; Arisawa, Y; Inada, T; Inoue, S; Ishibiki, K; Kodaira, S; Kubota, T; Kuzuoka, M; Suto, A | 1 |
Hattori, T; Jinushi, K; Kim, R; Kirihara, Y; Niimoto, M; Nishiyama, M; Saeki, T; Takagami, S; Toge, T | 1 |
1 trial(s) available for kt 6149 and Adenocarcinoma
Article | Year |
---|---|
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biotransformation; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Half-Life; Humans; Liver Neoplasms; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Unknown Primary; Salvage Therapy | 1995 |
4 other study(ies) available for kt 6149 and Adenocarcinoma
Article | Year |
---|---|
Reduced bone marrow toxicity of KW-2149, a mitomycin C derivative, in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; Colony-Forming Units Assay; Female; Hematopoietic Stem Cells; Lung Diseases; Male; Megakaryocytes; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mitomycin; Mitomycins; Organ Size; Spleen; Tumor Cells, Cultured | 1993 |
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation | 1990 |
Antitumor activity of 7-N-(2-((2-(gamma-L-glutamylamino) ethyl) dithio) ethyl) mitomycin C (KW2149) against human tumor xenografts serially transplanted into nude mice.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Random Allocation; Transplantation, Heterologous | 1989 |
[Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Infusions, Parenteral; Lethal Dose 50; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Stomach Neoplasms | 1988 |